Genmab A-S
Price & Volume
Stats
See more52W Range | $23.62-$35.66 |
Market Cap | $21.4B |
Shares Short | 6M |
Financials
See moreRevenue (12 Mos) | $4.1B |
Revenue Growth (YoY) | 24.9% |
Gross Profit (12 Mos) | $3.8B |
Diluted EPS | $1.27 |
News
See moreYahoo Finance • 29 days ago
Could Genmab (GMAB) Stock Win as Royalty Growth Fuels a New Earnings Cycle?
Yahoo Finance • last month
Could AbbVie Inc. (ABBV) Win as Genmab A/S (GMAB) Faces a New Regulatory Test for Epcoritamab?
Yahoo Finance • last month
Here Are Wednesday’s Top Wall Street Analyst Research Calls: The Gap, Genmab, Hilton Worldwide, Intuitive Surgical, Mariott International, Merck, Novo Nordisk, Okta, and More
Yahoo Finance • 2 months ago
Genmab Stock Rises 4.4% as Drug Royalties Lift Outlook
About
CEO | Dr. Jan G.J. van de Winkel Ph.D. |
CFO | Mr. Anthony Pagano CPA |
Address | Carl Jacobsens Vej 30, Copenhagen, Denmark, 2500 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 3,119 |